Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

GC-Ms, UHPLC-MS/MSn Phytoconstituents Characterization and Physio-pharmacological Investigation of Silene colorata subsp. amphorina (Pomel) Batt. From Northeastern Algeria

AI Summary
  • Comprehensive phytochemical profiling identified 57 GC-MS compounds (73.65% fatty acids and esters) and major UHPLC-MS/MS constituents including 2',4'-dihydroxychalcone (20.72%).
  • Hydro-alcoholic extract exhibited potent antioxidant activity (ABTS IC50 7.57 µg/mL) and high SPF (40.56); chloroform fraction inhibited α-amylase and BChE.
  • Molecular docking indicated a stable but antagonistic 3-tetradecyn-1-ol and α-amylase complex (−4.8 kcal/mol); authors call for further in vivo validation.
Summarise with AI (MRCPsych/FRANZCP)

Chem Biodivers. 2026 Aug;23(8):e71578. doi: 10.1002/cbdv.71578.

ABSTRACT

Natural remedies combined with bioinformatics accelerate the formulation of safer, targeted drugs. This study provides a comprehensive description of the phytochemical and pharmacological aspects of Silene colorata. Binding profiles of eight identified compounds were simulated against α-amylase. GC-MS analysis revealed 57 compounds, mainly fatty acids and esters (73.65%), while UHPLC-MS/MS identified 2′,4′-dihydroxychalcone (20.72%), (epi)gallocatechin-C-hexoside (12.53%), apigetrin (10.10%), and hexahydroxyheptanoic acid (8.57%) as major components. The hydro-alcoholic extract showed a strong antiradical effect (IC50 = 7.57 ± 0.26 µg/mL by ABTS assay; A0.50 = 48.93 ± 3.88 µg/mL by phenanthroline assay). Its sun protection factor (SPF) was also the highest (40.561 ± 0.87). The chloroform fraction showed notable activity against α-amylase (IC50 = 22.86 ± 3.19 µg/mL) and butyrylcholinesterase (IC50 = 111.08 ± 4.72 µg/mL). The complex 3-tetradecyn-1-ol and α-amylase appeared more stable, but in an antagonistic manner (-4.8 kcal/mol). While this work reveals crucial findings, further in vivo studies are needed to confirm and expand on these results.

PMID:42555847 | DOI:10.1002/cbdv.71578

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

Save as PDF

My Revision List

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review
← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD